Search results for

Just two weeks after Hurricane Eta dumped heavy rainfall in the region, Honduras, Guatemala, Nicaragua and southern Belize are facing an even stronger storm fueled by climate change.

NPR's Mary Louise Kelly talks with Dr. Tal Zaks, chief medical officer at Moderna, about its coronavirus vaccine, which is said to be nearly 95% effective, according to clinical trial data.

Deaf Americans are debating which sign should represent Joe Biden, who until now has been signed B-I-D-E-N. There's also chatter of picking a sign for Kamala Harris — a rarity for vice presidents.

NPR's Ari Shapiro talks with Dr. Helene Gayle, one of the co-chairs of the National Academies' framework for vaccine distribution, about how the coronavirus vaccine can be distributed equitably.

The data for 2019 show a slight overall increase but offenses were more violent than in previous years. About half of the 51 bias-motivated homicides stemmed from the Walmart mass shooting in Texas.

As coronavirus cases surge across the United States, a second vaccine candidate is said to show great promise. Experts say the first vaccines could become available as early as late December.

Officials hope to auction off leases before President-elect Joe Biden takes office. He has pledged to protect the pristine landscape that's home to polar bears and migrating caribou.

The city is taking sweeping steps to control the coronavirus by banning indoor activities, including holiday season gatherings among people of different households.

Only four other GOP senators have publicly called Democrat Joe Biden "president-elect" since the race was called for him over a week ago.

The U.S. biotech company Moderna announced its experimental COVID-19 vaccine is 94.5% effective. Operation Warp Speed science adviser Dr. Moncef Slaoui says he was ecstatic when he heard the news.